Azelnidipine, A Newly Developed Long-Acting Calcium Antagonist, Inhibits Tumor Necrosis Factor-α-Induced Interleukin-8 Expression in Endothelial Cells through its Anti-Oxidative Properties

• Sho-ichi Yamagishi

• Yosuke Inagaki

• Kazuo Nakamura

• Tsutomu Imaizumi

Journal

• Journal of Cardiovascular Pharmacology

  Journal of Cardiovascular Pharmacology 43 (5), 724-730, 2004-05

  Ovid Technologies (Wolters Kluwer Health)

Keywords

• Cardiology and Cardiovascular Medicine
• Pharmacology

Details

• CRID: 1362825894431960960
• NII Article ID: 30018798666
• DOI: 10.1097/00005344-200405000-00016
• ISSN: 01602446
• Web Site: http://journals.lww.com/00005344-200405000-00016
• Data Source:
  • Crossref
  • CiNii Articles